Us Bancorp \De\ Adma Biologics, Inc. Transaction History
Us Bancorp \De\
- $74.1 Billion
- Q1 2025
A detailed history of Us Bancorp \De\ transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 535 shares of ADMA stock, worth $12,684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
535
Previous 439
21.87%
Holding current value
$12,684
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ADMA
# of Institutions
354Shares Held
178MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$442 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$399 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$353 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$268 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$131 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.66B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...